{"public_id":"cl_de525c6b09d8cfe1e9ffb50eeababec3","status":"active","superseded_by_public_id":null,"corpus_id":39007876,"text":"Nitric oxide alone and nitric oxide plus eptifibatide improve postbypass platelet function and reduce plasma beta-thromboglobulin release compared with control animals.","confidence":0.97,"paper":{"corpus_id":39007876,"title":"Platelet anesthesia with nitric oxide with or without eptifibatide during cardiopulmonary bypass in baboons.","url":"https://sah.borca.ai/papers/39007876"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.97,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_027dba50f269d9e18e69767d947dcd74","name":"nitric oxide","description":"A short-acting, reversible platelet inhibitor evaluated during cardiopulmonary bypass.","types":["compound","therapeutic agent"],"url":"https://sah.borca.ai/concepts/co_027dba50f269d9e18e69767d947dcd74"},{"public_id":"co_2cc46f471fdeb3ffc8369cf35cedea39","name":"beta-thromboglobulin","description":"A plasma marker of platelet activation measured in blood samples.","types":["biomarker","measurement"],"url":"https://sah.borca.ai/concepts/co_2cc46f471fdeb3ffc8369cf35cedea39"},{"public_id":"co_8f409b7c9714305a00bba86d5943af95","name":"eptifibatide","description":"A short-acting, reversible glycoprotein IIb/IIIa inhibitor used with nitric oxide in the study.","types":["compound","therapeutic agent"],"url":"https://sah.borca.ai/concepts/co_8f409b7c9714305a00bba86d5943af95"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_de525c6b09d8cfe1e9ffb50eeababec3"}